Norplant: subdermal implant system for long-term contraception

American Journal of Obstetrics and Gynecology
D Shoupe, D R Mishell

Abstract

Norplant offers long-term contraception through the use of subdermal capsules filled with levonorgestrel. The six capsules are implanted in the inside part of the upper arm. The levonorgestrel is released from the capsules gradually, providing contraception for about 5 years. The primary mechanism of action of Norplant is suppression of ovulation. Studies have shown a pregnancy rate of 0.6/100 woman-years after 1 year and a cumulative rate of 1.5/100 woman-years at 5 years. Principal side effects are irregular menstrual bleeding and headaches. No changes in carbohydrate metabolism, blood coagulation, or liver function have been reported. Lipid levels have decreased 5% to 15%. After removal of Norplant, fertility returns rapidly, and there have been no adverse effects on infants. Norplant is currently approved in 12 countries; clinical trials are being conducted in 37 countries.

Citations

Aug 14, 1998·American Journal of Public Health·L L ClarkeM K Miller
Jun 1, 1993·Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception·M L FrankL Bateman
Apr 4, 1998·Journal of Pediatric and Adolescent Gynecology·P J Dias, N O'Mara
Apr 1, 1996·Baillière's Clinical Obstetrics and Gynaecology·J R Newton
Mar 1, 1995·Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners·K SmithT Parker
Mar 1, 1997·American Journal of Obstetrics and Gynecology·A B BerensonS L McCombs
Jan 1, 1995·American Journal of Obstetrics and Gynecology·D A PhemisterF N Harrison
Jan 14, 2011·Health Care for Women International·Haifa Abdulaziz Al-Turki
Aug 1, 1991·Contraception·J C KonjeO A Ladipo
Jun 1, 1994·Journal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN·L T Hinkle
Mar 1, 1995·Scandinavian Journal of Social Medicine·E OllilaK Kajesalo
Nov 3, 1994·The New England Journal of Medicine·M PolaneczkyS Sondheimer
Mar 23, 1995·The New England Journal of Medicine·R I Lewy
Sep 15, 2012·Chemistry & Biodiversity·Genevieve M HalpennyPradip K Mascharak
Dec 30, 1994·Annals of the New York Academy of Sciences·M J Legato
Nov 28, 2002·Clinical Pharmacokinetics·Yie W Chien, Senshang Lin
Dec 1, 1993·Clinical Pediatrics·P K Braverman, V C Strasburger
Aug 1, 1991·The Australian & New Zealand Journal of Obstetrics & Gynaecology·M Cooper
Jul 1, 1994·Journal of Health Education·R J Ogletree, K J Welshimer
May 1, 1995·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·S D Ammerman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.